Bloody Putin!
I agree other drug companies are delaying TIS CE. There is plenty of room in this huge industry for all to make money.
That said its easy to dick around a small cap Aussie Biotech than delay the big boys with deep pockets and the good litigation teams.
Approval teams only seem to be interested in harm caused by products not net benefit. Three more months now
EMA Fails to Follow Legislation and Its Own Policy, page-12
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
